Jynarque
Ended Awarded Last action
- Contract number
- 36C24622N0563
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 6
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $11,414
Award facts
- Contract value 100% obligated
- $11,413.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6850 Miscellaneous Chemical Specialties
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Pittsburgh, PA 15275, USA
Award details come from SAM.gov/FPDS.
About this award
Otsuka America Pharmaceutical Inc. received a $11,413.72 delivery order from the Department of Veterans Affairs' Veterans Integrated Service Network 6 (VISN 6) on March 21, 2022, for the supply of Jynarque (tolvaptan), a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia. This firm-fixed price contract, with an ultimate completion date of April 1, 2022, was issued without a set-aside designation and will be performed in Pittsburgh, Pennsylvania. The delivery order falls under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), reflecting the VA's established procurement vehicle for pharmaceutical products.
This delivery order is issued under Otsuka America Pharmaceutical Inc.'s broader Blanket Purchase Agreement valued at $83.3 million for Jynarque, which was awarded by the National Acquisition Center with completion through March 2026. The BPA enables VA Integrated Service Networks nationwide to efficiently procure this specialized pharmaceutical treatment for veterans. As a large pharmaceutical manufacturer headquartered in Rockville, Maryland, Otsuka America also maintains a $396 million Federal Supply Schedule contract for pharmaceuticals and hematology-related products, demonstrating significant established capability to support the VA's comprehensive healthcare delivery mission.
Quick answers
Who was awarded contract 36C24622N0563?
36C24622N0563 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 6 (Veterans Health Administration) on March 21, 2022.
How much is contract 36C24622N0563 worth?
The government has obligated $11,414 on 36C24622N0563.
Is contract 36C24622N0563 an order under another contract?
Yes. 36C24622N0563 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24622N0563 competed?
The extent of competition for 36C24622N0563 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award